• Home
  • About Us
    • Overview
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Privacy Policy
  • Our Portfolio
    • Arestat™
    • AT247 – Ultra-Rapid Acting Insulin
    • AT278 – Ultra-Concentrated Rapid Acting Insulin
    • Tetris Pharma Portfolio
  • What We Do
    • Arestat™
    • Differentiated biosimilars with IP Protection
    • Intravenous to subcutaneous switch
    • Lyophilised powder to liquid switch
    • High concentration antibodies
    • Superior peptides
    • Thermostable vaccines and therapeutics
  • Investors
    • Investor Centre
    • Regulatory News
    • Email alerts
    • Financial Information
    • Shareholder Information
    • FAQs and help
    • AIM Rule 26
    • Corporate Governance
    • Investor Relations Contacts
  • News & Events
  • Careers
  • Contact us
Home / Investor Centre / Regulatory News

Regulatory News

QUICK LINKS
  • Home
  • About Us
  • Our Portfolio
  • What We Do
  • News & Events
  • Careers
  • Contact
  • Privacy Policy
  • Disclaimer
FOLLOW US ON
Website designed by Carr Kamasa Design
Cookie Policy
Copyright Arecor © 2023

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Arecor
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

More information about our Cookie Policy